ArticleThe Lancet. Primary care2026

Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data.

Thijs T Jansz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.